Loading...

Targeting InhA, the FASII Enoyl-ACP Reductase: SAR Studies on Novel Inhibitor Scaffolds

The bacterial type II fatty acid biosynthesis (FASII) pathway is an essential but unexploited target for drug discovery. In this review we summarize SAR studies on inhibitors of InhA, the enoyl-ACP reductase from the FASII pathway in M. tuberculosis. Inhibitor scaffolds that are described include th...

Full description

Saved in:
Bibliographic Details
Published in:Curr Top Med Chem
Main Authors: Pan, Pan, Tonge, Peter J.
Format: Artigo
Language:Inglês
Published: 2012
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4397217/
https://ncbi.nlm.nih.gov/pubmed/22283812
Tags: Add Tag
No Tags, Be the first to tag this record!